Breast implant research
This article was originally published in The Gray Sheet
Executive Summary
House Energy & Commerce/Health subcommittee hearing on "The Breast Implant Research and Information Act" (HR 1961), may prompt bill's inclusion in a larger health-related measure this session, Energy & Commerce staffers say. Held Nov. 15, witnesses included National Center for Policy Research for Women and Families Executive Director Diana Zuckerman, MD, and two breast implant recipients. Introduced May 23 by Reps. Roy Blunt (R-Mo.) and Gene Green (D-Texas), the bill requires FDA to provide Congress with regular updates on the status of postmarket evaluations of saline breast implants (1"The Gray Sheet" May 28, 2001, p. 11). Senate companion legislation (S 961) was introduced by Sen. Barbara Boxer May 24...
You may also be interested in...
Breast Implant Research Bill Seeks CDRH Postmarket Reports To Congress
Regular updates to Congress from FDA on the status of postmarket evaluations of saline breast implant data would be required under HR 1961, a bill introduced by Reps. Roy Blunt (R-Mo.) and Gene Green (D-Texas) May 23.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.